Fetuses exposed to higher levels of air pollution during their mother’s third trimester of pregnancy have a higher risk of elevated blood pressure in childhood, according to a new study published online May 14 in the American Heart Association’s journal Hypertension.

Using data from the randomized COURAGE trial, a team of researchers developed a model to predict one-year angina and quality-of-life outcomes among patients with stable coronary artery disease (CAD).

Researchers have identified a genetic variant that may predispose individuals to alcoholic cardiomyopathy (ACM), possibly opening the door for genetic testing and familial evaluation.

Watchman-related thrombi developed in 3.7 percent of patients who were implanted with the device, resulting in a threefold risk of stroke or systemic embolism, according to a meta-analysis of clinical trials and registries published online May 11 in Circulation.

People with high concentrations of lipoprotein(a) in their blood may not get the same preventive benefit from statins, even if their LDL cholesterol is effectively lowered with the medication.

Preliminary research presented May 11 at the American Heart Association’s Vascular Discovery: From Genes to Medicine Scientific Sessions 2018, suggests an injection may one day be able to reverse atherosclerosis.

A novel device placed under the sternum outside of the heart and veins has the potential to deliver pacing and defibrillation therapy, according to a feasibility study presented at the Heart Rhythm Society’s annual scientific sessions.

A sensing filter added to Boston Scientific’s Emblem subcutaneous implantable cardioverter defibrillators (S-ICDs) more than halved the number of inappropriate shocks given to patients over a one-year period, according to a real-world European study presented May 11 at the Heart Rhythm Society’s annual scientific sessions in Boston.